AU1899099A - Agents - Google Patents

Agents

Info

Publication number
AU1899099A
AU1899099A AU18990/99A AU1899099A AU1899099A AU 1899099 A AU1899099 A AU 1899099A AU 18990/99 A AU18990/99 A AU 18990/99A AU 1899099 A AU1899099 A AU 1899099A AU 1899099 A AU1899099 A AU 1899099A
Authority
AU
Australia
Prior art keywords
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18990/99A
Inventor
Palok Aich
Jan Bergman
Astrid Graslund
Bengt Norden
Ulrica Sehlstedt
Hans Vallberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1899099A publication Critical patent/AU1899099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
AU18990/99A 1997-12-17 1998-12-16 Agents Abandoned AU1899099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9704723A SE9704723D0 (en) 1997-12-17 1997-12-17 ligands
SE9704723 1997-12-17
PCT/SE1998/002340 WO1999030712A1 (en) 1997-12-17 1998-12-16 Agents

Publications (1)

Publication Number Publication Date
AU1899099A true AU1899099A (en) 1999-07-05

Family

ID=20409439

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18990/99A Abandoned AU1899099A (en) 1997-12-17 1998-12-16 Agents

Country Status (7)

Country Link
EP (1) EP1037638A1 (en)
JP (1) JP2002508325A (en)
AP (1) AP2000001835A0 (en)
AU (1) AU1899099A (en)
IL (1) IL136525A0 (en)
SE (1) SE9704723D0 (en)
WO (1) WO1999030712A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022002898A1 (en) * 2020-06-29 2022-01-06 Vironova Medical Ab 6h-indolo(2,3-b)quinoxaline derivatives useful in therapy in particular in a virus infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8600260D0 (en) * 1986-01-21 1986-01-21 Lundblad Leif SUBSTITUTED INDOLOKINOXALINES
SE504289C2 (en) * 1994-06-23 1996-12-23 Leif J I Lundblad Use of certain indolo-2,3b-quinoxalins for the preparation of a drug for inhibiting the enzyme HIV integrase
SE504862C2 (en) * 1994-12-27 1997-05-20 Leif J I Lundblad Use of certain indolo- §2,3b-quinoxalines for the preparation of a drug for the protection of DNA in the initiation and / or promotional phase of carcinogenesis and for the prevention of oxidative stress in patients with diseases related to free radicals

Also Published As

Publication number Publication date
IL136525A0 (en) 2001-06-14
SE9704723D0 (en) 1997-12-17
EP1037638A1 (en) 2000-09-27
AP2000001835A0 (en) 2000-06-30
JP2002508325A (en) 2002-03-19
WO1999030712A1 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
AU1709299A (en) Mixer-injectors
AU8921698A (en) Follistatin-3
AU9414098A (en) Ascorbyl-phosphoryl-cholesterol
AU6598798A (en) Resorcinyl-triazines
AU1027499A (en) 32P-polyphosphazene
AU9513298A (en) Fluoranthenopyrans
AU5272198A (en) EMP-charge-eliminator
AU6998698A (en) Dioxacycloalkan-8-one
AU4117497A (en) Micropolarimeter
AU6185898A (en) Clavaspirins
AU7761998A (en) Korrosionsschutzanstrichstoff
AU8214598A (en) 3-benzylpiperidine
AU5391798A (en) Thiamacrolides
AU4469997A (en) Heregulin-gamma
AU8991998A (en) Renovative pipeliner
AU9183798A (en) Catamaran - bicycle - kayak
AU5540298A (en) Rockbolts
AU1899099A (en) Agents
AU3194197A (en) Stainblocking agent
AU6060598A (en) Multi-hopper
AU7780498A (en) Cafetiere
AU8121298A (en) G-seat
AU6237398A (en) N-het-substituted glycerophosphoethanolamines
AU6507298A (en) Renovative pipeliner
AUPO502797A0 (en) Weeaphone

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase